NanoVibronix Inc. (NAOV) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of NanoVibronix (NAOV)

High patent barriers for WoundWand and strict FDA oversight protect the business of NanoVibronix, Inc. (NAOV), which relies on growing demand in urology and the outpatient sector. Stock price volatility reflects a dependence on debt obligations, where the indicator stands at 0.00. Management, experts in acoustic waves, is currently developing portable tissue healing systems to expand insurance reimbursements and sales.

NAOV nanovibronix.com: Long-Term Debt to Equity in the range 07/04/2022 - 12/12/2025

Analytical breakdowns for NanoVibronix, Inc.

- share price and consensus valuation forecast:
Price nanovibronix.com|NAOV - Analyst Consensus Forecast
- market capitalization indicators:
Market Value NanoVibronix, Inc.|NAOV - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share NanoVibronix|NAOV - Company Book Value|Market Value to Book Value nanovibronix.com|NAOV - Company Total Assets
- debt and solvency information:
Total Debt to Capital NanoVibronix, Inc.|NAOV - Long-Term Debt to Equity|Current Liabilities to Equity NanoVibronix Inc.|NAOV - Company Aggregate Debts|Debts to Book Value NanoVibronix, Inc.|NAOV - Company Long-Term Liabilities|Company Short-Term Debts NanoVibronix|Intermediate Liquidity Ratio nanovibronix.com
- business earnings and investment ratios data:
NAOV - Net Profit
Summary company analysis:NAOV (nanovibronix.com)
Core merchandise of NanoVibronix Inc.

This metric measures the share of long-term liabilities within the equity structure, determining the issuer's financial stability. The ratio of loans with a maturity of more than one year to equity reveals the degree of debt load. The current value of 0.00 allows for an assessment of leverage risks. By analyzing the ratio of long-term loans to equity, an investor can identify the resource base for scaling. This is critical for NanoVibronix, Inc. (NAOV) during the expansion of the UroShield line within the hospital segment.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital IINN|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Long-Term Debt to Capital IRIX (IRIDEX)|Long-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Long-Term Debt to Equity|PFSA: Long-Term Debt to Equity|SSKN (strataskinsciences.com) - Long-Term Debt to Equity Ratio|GlucoTrack Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)